QSC supplies six oral anabolic-androgenic steroids (AAS) as research-grade tablet kits (100, 500, and 1000-count). All ≥99% HPLC purity with Janoshik independent COA. Research applications include muscle wasting, body composition, androgenic signalling, hepatic metabolism, SHBG binding, and anabolic-to-androgenic ratio comparisons.
Modified DHT — no aromatisation, SHBG reduction, l
Oxandrolone (Anavar)
322-630
24
No
Yes
Lowest androgenicity of oral AAS — preferred for s
Superdrol (Methasterone)
400
20
No
No
High anabolic potency, no aromatisation, hepatic m
Turinabol
~100
~6
No
Yes
Dianabol+Clostebol hybrid — anabolic without oestr
Proviron (Mesterolone)
~150
~40
No
No
DHT derivative — SHBG binding, anti-oestrogenic, m
17α-Alkylation and hepatotoxicity
Dianabol, Winstrol, Oxandrolone, and Turinabol are 17a-alkylated — prevents first-pass deactivation but introduces hepatotoxicity in chronic models. Superdrol is not 17a-alkylated but hepatotoxic via alternate mechanism. This structural distinction is a key variable in hepatic metabolism research design.